Knowledge is Empowering:
Understanding the Jewish - Cancer Connection
Wednesday, November 13, 2019
Temple Emanu-El, located in Marblehead, Massachusetts, will host this Oneinforty symposium to educate the community about Ashkenazi Jews' one-in-forty risk of inheriting a BRCA gene mutation. Having a BRCA gene mutation significantly increases one's risk of developing breast, ovarian, prostate and other cancers that, in many cases, can be prevented or detected early.
Panelists will discuss genetic counseling, the rationale for testing for BRCA gene mutations, managing cancer risk and resources available for those who carry BRCA gene mutations. You will also learn about the BRCA Founder Outreach (BFOR) Study that offers free screening for the three BRCA founder mutations through Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Memorial Sloan Kettering, Cedars-Sinai Medical Center, Penn Medicine and the Basser Center for BRCA. Jewish individuals who have a BRCA gene mutation will share their stories. Following presentations by each of the panelists listed below, there will be a Q&A session.
Betty Cooperstein, LICSW
Medical Advisory Board Member
Social worker in private practice
BRCA-positive ovarian cancer patient
Leif Ellisen, MD, PhD
Program Director, Breast Medical Oncology
MGH Cancer Center
Alison Roberston, MS, LGC
Licensed Genetic Counselor
Center for Cancer Genetics and Prevention
Dana-Farber Cancer Institute
This symposium is free-of-charge and open to the general public. Kosher refreshments will be served.
Questions? Please contact Allison O'Hara at 508-330-8807 or firstname.lastname@example.org
Presented by Oneinforty, a nonprofit organization that raises awareness of the one-in-forty risk to Ashkenazi Jews of inheriting BRCA gene mutations and provides support individuals and families need to effectively manage their cancer risk.